Table 1 (abstract P358). Baseline Patient Characteristics
From: Proceedings of the 25th European Paediatric Rheumatology Congress (PReS 2018)
| Â | Total (n= 320) | Step up (n= 211) | Early Combination (n=77) | Biologic First (n=32) |
|---|---|---|---|---|
Female N (%) | 232 (72) | 156 (74) | 55 (71) | 21 (66) |
White N (%) | 218 (68) | 152 (72) | 48 (65) | 18 (56) |
Age in yrs – mean  (range) | 10 (1-18) | 10 (1-18) | 11 (1-18) | 11 (1-18) |
Number of Active joints - mean (range) | 13 (5-50) | 12 (5-49) | 16 (5-50) | 11 (5-41) |
Physician Global Assessment of Disease Activity - mean (range) | 5 (0-10) | 5 (0-10) | 6 (1-10) | 6 (1-10) |
Juvenile Arthritis Disease Activity Score - mean (range) | 18 (5-29) | 17 (5-29) | 20 (6-29) | 20 (14-28) |
CHAQ Score - mean (range) | 1 (0-3) | 1 (0-3) | 1 (0-3) | 1 (0-3) |
Oral steroids prescribed at baseline - N (%) | 84 (26) | 57 (27) | 22 (29) | 5 (16) |